Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
09/2000
09/12/2000US6116097 Method and means for detecting chemicals on ground
09/12/2000US6116079 Liquid copper hydrogen sample probe
09/12/2000CA2300460A1 Gas sensor
09/10/2000CA2300250A1 Method and apparatus for the detection of foreign materials in moving textile materials
09/09/2000CA2300540A1 Powder analysis
09/08/2000WO2000052480A1 Method for assaying biological sample component
09/08/2000WO2000052479A2 Diagnostics and therapeutics for drusen associated ocular disorders
09/08/2000WO2000052477A1 Method and in vitro kit for selecting a drug for chemotherapy
09/08/2000WO2000052476A1 Method for diagnosing and distinguishing stroke
09/08/2000WO2000052475A1 Method for evaluating the intensity of muscular proteolysis
09/08/2000WO2000052474A1 Electrochemiluminescent assays for eukaryotic cells
09/08/2000WO2000052473A2 Radiolabeling kit and binding assay
09/08/2000WO2000052472A1 Rapid assay for infection in small children
09/08/2000WO2000052471A1 Rapid assay for chorioamnionitis
09/08/2000WO2000052470A1 Diagnostics and remedies for leukemia
09/08/2000WO2000052469A1 Method for assaying crp with the use of phosphorylcholine
09/08/2000WO2000052468A1 Method and apparatus for controlling the adsorption of a liquid sample through an absorbent layer
09/08/2000WO2000052467A1 Methods of determining altered ndpk functions
09/08/2000WO2000052466A2 Measurement of tear fluorescein clearance
09/08/2000WO2000052464A1 Reagent and method for detecting an adulterant in an aqueous sample
09/08/2000WO2000052463A1 Method of diagnosing and monitoring malignant breast carcinomas
09/08/2000WO2000052462A1 Heart abnormalities in vascular endothelial growth factor b (vegf-b) deficient animals and methods relating to these heart abnormalities
09/08/2000WO2000052457A1 Card-based biosensor device
09/08/2000WO2000052456A1 Biosensor device and method
09/08/2000WO2000052448A1 Device for measuring alterations in reheated edible oils
09/08/2000WO2000052447A1 Device for evaluating granule hardness
09/08/2000WO2000052446A1 Methods and apparatus for separation of biological fluids
09/08/2000WO2000052445A1 Apparatus for removing water from dielectric oil in electrical power transformers
09/08/2000WO2000052444A2 Apparatus, systems and methods for detecting and transmitting sensory data over a computer network
09/08/2000WO2000052439A1 Capacitive force gauge
09/08/2000WO2000052264A1 Method and apparatus for measuring properties of a moving fiber web
09/08/2000WO2000052210A2 Methods for targeting rna molecules
09/08/2000WO2000052208A2 Customized oligonucleotide microchips that convert multiple genetic information to simple patterns
09/08/2000WO2000052199A1 Determination of biologically active forms of proteolytic enzymes
09/08/2000WO2000052197A1 BLOOD SERUM SAMPLE PREPARED FOR ISOLATION OF PRIONS AND PrP?Sc¿
09/08/2000WO2000052195A1 Viability assay for sporocyst-forming protozoa
09/08/2000WO2000052178A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells
09/08/2000WO2000052054A2 Antibodies for cancer therapy and diagnosis
09/08/2000WO2000052053A1 Antibodies against phosphomannan that are protective against candidiasis
09/08/2000WO2000052048A1 Modulators of beta-amyloid peptide aggregation comprising d-amino acids
09/08/2000WO2000052046A1 Immunomodulating glycopeptide
09/08/2000WO2000052044A1 Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof
09/08/2000WO2000052041A1 Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with porphyromonas gingivalis
09/08/2000WO2000052040A1 Hiv peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by hiv
09/08/2000WO2000052031A2 Kit for radiolabeling proteins with yttrium-90
09/08/2000WO2000052022A1 Secreted proteins and nucleic acids encoding them
09/08/2000WO2000051814A1 Simultaneous analysis of an analyte and an interfering substance using flow cytometry
09/08/2000WO2000051632A2 COPPER AGONIST THAT BINDS ON THE COPPER BINDING SITE OF APP AND/OR EXERTS AN INHIBITING EFFECT ON THE RELEASE OF AMYLOID Aβ PEPTIDE
09/08/2000WO2000051520A2 Bovine pregnancy testing
09/08/2000WO2000051470A1 Apparatus for the assessment of mattresses
09/08/2000WO2000051423A1 Herpes simplex virus reactivation model
09/08/2000WO2000036097A3 Methods for regulating vascularization using gef containing nek-like kinase (gnk)
09/08/2000WO2000034789A3 Method for determining asthma susceptibility
09/08/2000WO2000031541A3 Method of detecting neurofibromatosis type 1
09/08/2000WO2000031535A3 Thyroid peroxidase autoantibody assay compositions, method and kit
09/08/2000WO2000029847A3 Device and method for analyzing a biologic sample
09/08/2000WO2000029583A3 Immunoglobulin superfamily proteins
09/08/2000WO2000028070A3 Detection of prostatitis
09/08/2000WO2000026668A3 S100 proteins and autoantibodies as serum markers for cancer
09/08/2000WO2000023590A3 INHIBITION OF CD40-MEDIATED NFλB ACTIVATION
09/08/2000WO2000020026A3 Compositions and methods for inhibiting angiogenesis
09/08/2000WO2000019883A3 Compositions and methods of disease diagnosis and therapy
09/08/2000WO2000019206A9 Ykl-40 as a marker and prognostic indicator for cancers
09/08/2000WO2000018960A3 Methods and products related to genotyping and dna analysis
09/08/2000WO2000018238A9 Identification of differentially methylated and mutated nucleic acids
09/08/2000WO2000013702A3 Use of an angiogenic factor for the treatment of microvascular angiopathies
09/08/2000WO2000013651A3 Luciferase reporter bioassay of parathyroid hormone compounds
09/08/2000WO2000013010A9 Systems and methods for fenceline air monitoring of airborne hazardous materials
09/08/2000WO2000012702A3 Human genes differentially expressed in colorectal cancer
09/08/2000WO2000012546A9 MAMMALIAN elk POTASSIUM CHANNEL GENES
09/08/2000WO2000011223A9 Use of pooled probes in genetic analysis
09/08/2000WO1999064595A9 THERAPEUTIC AND DIAGNOSTIC DOMAIN 1 β2GPI POLYPEPTIDES AND METHODS OF USING SAME
09/08/2000CA2742153A1 Method for radiolabeling a chelator-conjugated antibody with 111ln
09/08/2000CA2371934A1 Copper agonist that binds on the copper binding site of app and/or exerts and inhibiting effect on the release of amyloid a.beta. peptide
09/08/2000CA2368976A1 Method and in vitro kit for selecting a drug for chemotherapy
09/08/2000CA2363957A1 Immunomodulating glycopeptide
09/08/2000CA2363570A1 Method for assaying biological sample component
09/08/2000CA2363568A1 Diagnostic agent and therapeutic agent for leukemia
09/08/2000CA2363566A1 Method of diagnosing and monitoring malignant breast carcinomas
09/08/2000CA2363498A1 Method for evaluating the intensity of muscular proteolysis
09/08/2000CA2363488A1 Heart abnormalities in vascular endothelial growth factor b (vegf-b) deficient animals and methods relating to these heart abnormalities
09/08/2000CA2363128A1 Method and apparatus for measuring properties of a moving fiber web
09/08/2000CA2363077A1 Methods for targeting rna molecules
09/08/2000CA2363073A1 Customized oligonucleotide microchips that convert multiple genetic information to simpler patterns, are portable and reusable
09/08/2000CA2362986A1 Blood serum sample prepared for isolation of prions and prpsc
09/08/2000CA2362924A1 Secreted proteins and nucleic acids encoding them
09/08/2000CA2362840A1 Antibodies against phosphomannan that are protective against candidiasis
09/08/2000CA2361877A1 Antibodies for cancer therapy and diagnosis
09/07/2000DE19939208A1 Verfahren zum Darstellen von biologisch aktivierten ferromagnetischen Partikeln sowie Vorrichtung dafür A method for displaying biologically activated ferromagnetic particles and apparatus thereof
09/07/2000DE19909703A1 Vorrichtung zur optischen Garnüberwachung Device for yarn monitoring optical
09/07/2000DE19909443A1 Detector for continuously determining volume of sample in closed test space has bell-shaped container for sealing-fluid and connector for level regulator
09/07/2000DE19909357A1 Kupferagonist, der an die Kupferbindungsstelle von APP bindet und/oder eine hemmende Wirkung auf die Freisetzung des Amyloid-Aß-Peptids ausübt Kupferagonist which binds to the copper binding site of APP and / or exerts an inhibitory effect on the release of the amyloid Aß-peptide
09/07/2000DE19908885A1 Method for operating gas burner by heating gas in separated measurement chamber and using relationship between and pressure or temperature to measure gas composition
09/07/2000DE19907573A1 Bore tool for testing trees and construction timber with and without cutting carbonises and gasifies removed wood using surface of bevelled cutter
09/07/2000DE19907463A1 Lysimeterstation Lysimeter
09/07/2000DE19906151A1 Verfahren und Vorrichtung zum Bestimmen des TOC-Gehaltes in wäßrigen Proben Method and apparatus for determining the TOC content in aqueous samples
09/07/2000DE19904088A1 Schlauchset für einen Zellseparator zum Separieren von Blut in seine Komponenten und Verfahren zum Separieren von Blut in seine Komponenten Hose for a cell separator for separating blood into its components and methods for separating blood into its components
09/07/2000DE19860833C1 Methode zur zellulären High-Throughput(Hochdurchsatz)-Detektion von Rezeptor-Liganden-Interaktionen Method for high-throughput cellular (high throughput) detection of receptor-ligand interactions
09/06/2000EP1033577A2 Test piece holder and apparatus for removing analyte excess incorporating the same
09/06/2000EP1033576A2 Method of preparing sample for amino acid analysis and kit for analyzing the same
1 ... 3077 3078 3079 3080 3081 3082 3083 3084 3085 3086 3087 3088 3089 3090 3091 3092 3093 3094 3095 3096 3097 ... 3937